These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16240890)

  • 41. Let's not forget the Third World.
    Rhame F
    Minn Med; 2009 Oct; 92(10):38-9. PubMed ID: 19916272
    [No Abstract]   [Full Text] [Related]  

  • 42. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
    Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
    AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. U.S. is lone holdout on drug access vote.
    AIDS Policy Law; 2003 Jan; 18(1):1. PubMed ID: 12569860
    [No Abstract]   [Full Text] [Related]  

  • 45. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment.
    Kline MW
    Pediatrics; 2006 Apr; 117(4):1388-93. PubMed ID: 16585337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda.
    Au JT; Kayitenkore K; Shutes E; Karita E; Peters PJ; Tichacek A; Allen SA
    AIDS; 2006 Oct; 20(16):2116-8. PubMed ID: 17053359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z; Simcock J
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Drug resistance in HIV infection].
    Asjö B; Langeland N
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2593-6. PubMed ID: 19023373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The future of HIV vasculopathy when our patients are on antiretroviral therapy.
    Barry R
    S Afr J Surg; 2009 May; 47(2):58, 60. PubMed ID: 19626782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.
    Harries AD; Makombe SD; Schouten EJ; Ben-Smith A; Jahn A
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):310-1. PubMed ID: 18316103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Access to antiretrovirals among people with HIV in poorer nations approaches 50%.
    Zarocostas J
    BMJ; 2009 Sep; 339():b4002. PubMed ID: 19793789
    [No Abstract]   [Full Text] [Related]  

  • 53. Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries.
    Cohen GM
    AIDS; 2007 Jul; 21 Suppl 4():S81-7. PubMed ID: 17620757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New challenges in therapeutic management of human immunodeficiency virus-infected children].
    Faye A
    Arch Pediatr; 2007 Feb; 14(2):212-8. PubMed ID: 17222540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Global good news: many more treated.
    AIDS Treat News; 2005 Jan; (409):6-7. PubMed ID: 15791715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New public/private sector effort initiated to accelerate access to HIV/AIDS care and treatment in developing countries.
    Int J Epidemiol; 2000 Oct; 29(5):956. PubMed ID: 11034986
    [No Abstract]   [Full Text] [Related]  

  • 58. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Universal access to antiretroviral therapy: when, not if.
    Carpenter CC
    Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
    [No Abstract]   [Full Text] [Related]  

  • 60. Scaling up antiretroviral treatment in resource-limited settings: successes and challenges.
    Katabira ET; Oelrichs RB
    AIDS; 2007 Jul; 21 Suppl 4():S5-10. PubMed ID: 17620753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.